alprazolam has been researched along with Dysthymia in 1 studies
Alprazolam: A triazolobenzodiazepine compound with antianxiety and sedative-hypnotic actions, that is efficacious in the treatment of PANIC DISORDERS, with or without AGORAPHOBIA, and in generalized ANXIETY DISORDERS. (From AMA Drug Evaluations Annual, 1994, p238)
alprazolam : A member of the class of triazolobenzodiazepines that is 4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine carrying methyl, phenyl and chloro substituents at positions 1, 6 and 8 respectively. Alprazolam is only found in individuals that have taken this drug.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Santagostino, G | 1 |
| Cucchi, ML | 1 |
| Frattini, P | 1 |
| Zerbi, F | 1 |
| Di Paolo, E | 1 |
| Preda, S | 1 |
| Corona, GL | 1 |
1 trial available for alprazolam and Dysthymia
| Article | Year |
|---|---|
The influence of alprazolam on the monoaminergic neurotransmitter systems in dysthymic patients. Relationship to clinical response.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Biogenic Monoamines; Blood Platelets; Dexamethasone; Dopamin | 1998 |